Cantor Fitzgerald and Sarah James lowered price targets on Centene Corporation.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald and Sarah James lowered price targets on Centene Corporation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Centene Corporation
American multinational healthcare company
Nothing else this week.
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald raised its price target on Texas Instruments shares on July 8, 2026.
- Cantor Fitzgerald and Wells Fargo raised price targets for Regeneron Pharmaceuticals stock.
- Cantor Fitzgerald raised its price target on Salesforce on September 1, 2026.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald decreased its price target on BigBear.ai on September 13, 2026.
Coverage
Newest first; wire copies grouped- Insider MonkeyCantor Fitzgerald Lowers PT on Centene Corporation (CNC) to $65 From $90, Keeps an Overweight Rating Centene Corporation (NYSE:CNC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential